Tag: Ingrid Skop

Supreme Court Tosses Doctors’ Challenge to Abortion Pill

Minnesota Sun Staff
Mifepristone boxes

The Supreme Court sided unanimously Thursday against several doctors and pro-life medical associations who brought a challenge to the abortion pill.

In FDA v. Alliance for Hippocratic Medicine, the Supreme Court held that the doctors do not have standing to challenge the U.S. Food and Drug Administration’s (FDA) decision to roll back safety regulations for the abortion pill. While recognizing the plaintiffs have “sincere legal, moral, ideological, and policy objections to elective abortion and to FDA’s relaxed regulation of mifepristone,” Justice Brett Kavanaugh wrote in the majority rulings that those kind of objections are not enough to show the doctors would be injured by the FDA’s actions, noting the federal courts are “the wrong forum” for addressing their concerns.

Read More

Latest ‘Rhetorical Game’ of Anti-Life Abortion Lobby: Sue Pro-Life States with Claim Women’s Lives Are at Risk Without Abortion

Susan Berry, PhD

The latest scheme of the anti-life abortion industry is to encourage lawsuits against states that have largely banned the procedure with the apparent claim seriously at-risk women who reside in those states are being denied allowable emergency medical care because providers are afraid of professional and criminal consequences.

As The New York Times reported Monday, five women are suing the state of Texas with the claim they were denied emergency medical care, despite life-threatening risks to themselves and their unborn babies, because their medical providers refused to give the care necessary for their dire situations due to possible punitive consequences resulting from the state’s abortion ban.

Read More

FDA Approves Chemical Abortion Pills to Be Sold at Retail Pharmacies

Susan Berry, PhD

The Food and Drug Administration (FDA) made a regulatory change that allows independent and chain drugstores, as well as mail-order companies, to offer a drug that induces abortion, making it easier for women and girls to conduct their own abortions at home or in college dorms.

The New York Times reported Tuesday evening the FDA’s regulatory change, which apparently came without an official announcement to the public, officially removes the requirement for the patient to have an in-person doctor’s visit for the prescription of mifepristone, the first drug used to induce an abortion.

Read More

Report: FDA Concerned Providers Prescribing Abortion-Inducing Drugs for Women Who Are Not Pregnant

Susan Berry, PhD

The Food and Drug Administration (FDA) says abortion providers are prescribing abortion-inducing drugs to women in advance of becoming pregnant – a practice that is without authorization and potentially dangerous for women.

“The FDA is concerned about the advance prescribing of mifepristone for this use,” an anonymous FDA spokesperson reportedly told the German-owned Politico Friday. “Mifepristone is not approved for advance provision of a medical abortion.”

Read More

Fact Check: Abortion Advocates’ Claim State Pro-Life Laws Endanger Lives of Pregnant Women Is False

Susan Berry, PhD

The abortion industry and its allies in politics, the media, and establishment medicine have made the false claim that women’s health is endangered by state pro-life laws because abortions cannot be performed in these states when the life of the mother is at risk.

Legal and medical experts, however, are explaining how that claim is false and constitutes “misinformation,” since pro-life laws in all states clearly articulate the lives of pregnant women are protected under them.

Read More